Heart failure therapy in patients with coronary artery disease

2012, European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure 2012, Eur Heart J, 33, 1787 Torabi, 2008, The timing of development and subsequent clinical course of heart failure after myocardial infarction, Eur Heart J, 29, 859, 10.1093/eurheartj/ehn096 Ho, 2012, Discriminatary clinical features of heart failure with preserved ejection fraction vs. reduced ejection fraction in the community, Eur Heart J, 33, 1734, 10.1093/eurheartj/ehs070 Ezekowitz, 2009, Declining in-hospital mortality and increasing heart failure incidence in elderly patients with first myocardial infarction, J Am Coll Cardiol, 53, 13, 10.1016/j.jacc.2008.08.067 Westermann, 2008, Role of left ventricular stiffness in heart failure with normal ejection fraction, Circulation, 117, 2051, 10.1161/CIRCULATIONAHA.107.716886 Gheorghiade, 1998, Chronic heart failure in the United States. A manifestation of coronary artery disease, Circulation, 97, 282, 10.1161/01.CIR.97.3.282 deBoer, 2011, High-risk patients with ST-elevation myocardial infarction derive greatest absolute benefit from primary percutaneous coronary intervention: results from the Primary Coronary Angioplasty Trialist versus thrombolysis (PCAT)-2 collaboration, Am Heart J, 161, 500, 10.1016/j.ahj.2010.11.022 Bleumink, 2004, Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure, Eur Heart J, 25, 1614, 10.1016/j.ehj.2004.06.038 Davies, 2001, Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study, Lancet, 358, 439, 10.1016/S0140-6736(01)05620-3 Stewart, 2001, More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure, Eur J Heart Fail, 3, 315, 10.1016/S1388-9842(00)00141-0 Jemtel, 2007, Diagnostic and therapeutic challenges in patients with co-existent chronic obstructive pulmonary disease and chronic heart failure, J Am Coll Cardiol, 49, 171, 10.1016/j.jacc.2006.08.046 Rutten, 2005, Unrecognised heart failure in elderly patients with stable chronic obstructive pulmonary disease, Eur Heart J, 26, 1887, 10.1093/eurheartj/ehi291 Escobar c, 2011, Diagnosis of heart failure in elderly patients: a clinical challenge, Eur J Heart Fail, 13, 1152, 10.1093/eurjhf/hfr105 Mant, 2009, Systematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in primary care, Health Technol Assess, 13, 10.3310/hta13320 National Institute for Clinical Excellence, 2010 Hobbs, 2004, Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations, Heart, 90, 866, 10.1136/hrt.2003.014258 Taylor, 2012, Ten-year prognosis of heart failure in the community: follow up data from the Echocardiographic Heart of England Screening Study (ECHOES), Eur J Heart Fail, 14, 176, 10.1093/eurjhf/hfr170 National Institute for Health and Clinical Excellence, 2007 The SOLVD Investigators, 1991, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators, N Engl J Med, 325, 293, 10.1056/NEJM199108013250501 Pfeffer, 1992, Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators, N Engl J Med, 327, 669, 10.1056/NEJM199209033271001 1999, The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial, Lancet, 353, 9, 10.1016/S0140-6736(98)11181-9 Pitt, 2003, Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators, N Engl J Med, 348, 1309, 10.1056/NEJMoa030207 Pitt, 2005, The role of aldosterone blockade in patients with heart failure, Heart Fail Rev, 10, 79, 10.1007/s10741-005-2352-2 National Institute for Health and Clinical Excellence, 2011 Cohn, 1991, A comparison of enalapril with hydralazine–isosorbide dinitrate in the treatment of chronic congestive heart failure, N Engl J Med, 325, 303, 10.1056/NEJM199108013250502 Swedberg, 2010, Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study, Lancet, 376, 875, 10.1016/S0140-6736(10)61198-1 Wijns, 2010, Guidelines on myocardial revascularization, Eur Heart J, 31, 2501, 10.1093/eurheartj/ehq277 Kjekshus, 2007, Rosuvastatin in older patients with systolic heart failure, N Engl J Med, 357, 2248, 10.1056/NEJMoa0706201 Ryan, 2009, Statins in HF: retrospective cohort study using routine primary care data, Ann Med, 41, 490, 10.1080/07853890903022819 Taylor, 2009, Type 2 diabetes, thiazolidinediones and cardiovascular risk, Br J Gen Pract, 59, 520, 10.3399/bjgp09X453440 Cleland, 2006, The perindopril in elderly people with chronic heart failure (PEP-CHF) study, Eur Heart J, 27, 2338, 10.1093/eurheartj/ehl250 Yusuf, 2003, Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial, Lancet, 362, 777, 10.1016/S0140-6736(03)14285-7 Paulus, 2010, Treatment of heart failure with normal ejection fraction. An inconvenient truth!, J Am Coll Cardiol, 55, 526, 10.1016/j.jacc.2009.06.067 Dickstein, 2010, Eur J Heart Fail, 12, 1143, 10.1093/eurjhf/hfq192 Tang, 2010, Cardiac-resynchronization therapy for mild-to-moderate heart failure, N Engl J Med, 363, 2385, 10.1056/NEJMoa1009540 Moss, 2009, Cardiac-resynchronization therapy for the prevention of heart-failure events, N Engl J Med, 361, 1329, 10.1056/NEJMoa0906431 Ptaszek, 2012, Towards regenerative therapy for cardiac disease, Lancet, 379, 933, 10.1016/S0140-6736(12)60075-0